1. Home
  2. SURG vs CELU Comparison

SURG vs CELU Comparison

Compare SURG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$1.70

Market Cap

47.6M

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.14

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
CELU
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
50.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
CELU
Price
$1.70
$1.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.75
$6.00
AVG Volume (30 Days)
161.2K
88.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
$40,578,000.00
Revenue This Year
$7.13
N/A
Revenue Next Year
$122.51
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$1.00
52 Week High
$3.47
$4.35

Technical Indicators

Market Signals
Indicator
SURG
CELU
Relative Strength Index (RSI) 44.37 32.86
Support Level $1.63 $1.01
Resistance Level $1.95 $1.37
Average True Range (ATR) 0.17 0.14
MACD 0.03 -0.02
Stochastic Oscillator 45.99 22.38

Price Performance

Historical Comparison
SURG
CELU

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: